Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03345134
Title Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without Nephroureterectomy
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Shaheen Alanee
Indications

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma

Therapies

BCG solution + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.